Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,580.06
(
0.22%
)
US TECH 100
29,522.00
(
0.33%
)
Dow Jones
51,032.46
(
0.72%
)
Brent Oil
91.36
(
0.00%
)
Bitcoin
73,466.32
(
0.13%
)
News Focus
News Focus
Post# of 1162
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

theswordman

Send PM Follow Ignore
Followers 22
Posts 3779
Boards Moderated 2
Alias Born 06/05/2020

theswordman

Re: Whalatane post# 658

Thursday, 07/31/2025 3:49:05 PM

Thursday, July 31, 2025 3:49:05 PM

Post# of 1162
You should read more and type less. Your opinion stated as fact is 100% wrong.

The adult AKI trial--"NEUTRALIZE-AKI" is set for interim analysis of 100 patients

The endpoint is a composite--mortality AND dialysis dependence (dialysis free) --MAKE 90

The trial is NCT05758077--found here: https://clinicaltrials.gov/study/NCT05758077?term=seastar&intr=scd&rank=2

There does not need any "modeling I've seen"--the trial is listed--try reading
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ICU News
More ICU News